After Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced a strategic joint venture for the development and commercialization of its oral medication delivery technology, the company’s shares
After releasing a letter to shareholders, Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares has seen a significant increase on the US stock charts. As of the
Oramed Inc. (NASDAQ: ORMP) stock surged by 13.32% in last trading closed whereas the ORMP stock rises by 58.86% during pre-market trading session after Oramed
NanoVibronix Inc. (NASDAQ: NAOV) shares are trading down -4.55% at $1.05 at the time of writing after announcing $6.0 million private placement. Company’s 52-week ranged
FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.